Glucose, metformin, and AICAR regulate the expression of G protein-coupled receptor members in INS-1 β cell

Hormone and Metabolic Research

Volumn 41, Issue 11, 2009, Pages 799-804

  Pan, Q R ^a   Li, W H ^a   Wang, H ^a   Sun, Q ^a   Xiao, X H ^a   Brock, B ^b   Schmitz, O ^b,c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Beta cells; Glucose; Incretins; Metformin

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; DACTINOMYCIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 40; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN-SECRETING CELLS; METFORMIN; RATS; RECEPTORS, G-PROTEIN-COUPLED; RIBONUCLEOTIDES;

EID: 70649104753     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1234043     Document Type: Article

References (28)

1. Del Prato S, Marchetti P. Beta- and alpha-cell dysfunction in type 2 diabetes. Horm Metab Res 2004; 36: 775-781
2. Brawn AJ, Jupe S, Briscoe CP. A family of fatty acid binding receptors. DNA Cell Biol 2005; 24: 54-61
3. Yamada Y, Seino Y. Physiology of GIP - a lesson from GIP receptor knockout mice. Horm Metab Res 2004; 36: 771-774 (Pubitemid 40115898)
4. Meier JJ, Nauck MA. GIP as a potential therapeutic agent? Horm Metab Res 2004; 36: 859-866
5. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi Jf, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shtn, Hinuma S, Fujisawa Y, Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003; 422: 173-176
6. Briscoe CP, Tadayyon M, Andrews JL, Benson WC, Chambers JK, Eifert MM, Ellis C, Elshourbagy NA, GoetzAS, Minnkk DT, Murdock PR, Sauls HR, Shabon U, Spinage LD, Strum JC, Szekeres PG, Tan KB, Way DM, Wilson S, Muir AL The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 2003; 278: 11303-11311
7. Shapiro H, Shachar S, Sekler I, Hershfinkel M, Walker MD. Role of GPR40 in fatty acid action on the beta cell line INS-IE, Biochem. Biophys Res Commun 2005; 335: 97-104
8. Schnell S, Schaefer M, Schofl C. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. MoI Cell Endocrinol 2007; 263: 173-180 (Pubitemid 44834553)
9. Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 2005; 1: 245258 (Pubitemid 43960613)
10. Bensellam M, Van Lommel L, Overbergh L, Schuit FC, Jonas JC. Cluster analysis of rat pancreatic islet gene mRNA levels after culture in low-, intermediate- and high-glucose concentrations. Diabetologia 2009; 52: 463-476
11. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase-development of the energy sensor concept. J Physiol 2006; 574: 7-15 (Pubitemid 43905792)
12. Lynn FC, Thompson SA, Pospisilik JA, Ehses JA, Hinke SA, Pamir N, Mcintosh CH, Pederson RA. A novel pathway for regulation of glucosedependent insulinotropic polypeptide (G1P) receptor expression in beta cells. FASEB J 2003; 17: 91-93
13. Ling Z, Kiekens R, Mahler T, Schuit K, Pipeleers-Marichal M, Sener A, Klöppel G, Malaisse WJ, Pipeleers DG. Effects of chronically elevated glucose levels on the functional properties of rat pancreatic ß-cells. Diabetes 1996; 45:1774-1782 (Pubitemid 26398959)
14. Path G, Opel A, Knoll A, SeufertJ. Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growth. Diabetes 2004; 53 (Suppl 1): S82-S85
15. Hoist JJ, Gromada J, Nauck MA. The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia 1997; 40:984-986 (Pubitemid 27316583)
16. Lynn FC, Pamir N, NgEH, Mcintosh CH, Kieffer TJ, Pederson RA. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. Diabetes 2001; 50:1004-1011 (Pubitemid 32374530)
17. Nauck MA, Heimesaat MM, Orskov C, Hoist JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993; 91: 301-307 (Pubitemid 23037285)
18. Kjems LL, Hoist JJ, Volund A, Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 2003; 52: 380-386
19. Valverde I, Wang GS, Burghardt K, Kauri LM, Redondo A, Acitores A, Villanueva-Penacarrillo ML, Courtois P, Sener A, Cancelas J, Malaisse WJ, Scott FW. Bioactive GLP-1 in gut, receptor expression in pancreas and insulin response to GLP-1 in diabetes-prone rats. Endocrine 2004; 23: 77-84 (Pubitemid 38621642)
20. Xu G, Kaneto H, Laybutt DR, Duvivier-Kali VF, Trivedi N, Suzuma K, King GL, Wer GC, Bonner-Weir S. Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 2007; 56:1551-1558 (Pubitemid 46842610)
21. Da S, X, Leclerc I, Varadi A, Tsuboi T, Moule SK, Rutter GA. Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem J 2003; 371: 761-774
22. Kefas BA, Cai Y, Kerckhofs K, Ling Z, Martens G, Heimberg H, Pipàeers D, Van de CM. Metfbrmin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem Pharmacol 2004; 68: 409-416
23. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D, Van de CM. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J MoI Endocrinol 2003; 30:151-161 (Pubitemid 36592509)
24. Kefas BA, Heimberg H, Voulant S, Meisse D, Hue L, Pipeleers D, Van de CM. AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 2003; 46: 250-254
25. PoId R, Jensen LS, Jessen N, Buhl ES, Schmitz O, flyvbjerg A, Fujii N, Goodyear LJ, Gotjredsen CF, Brand CL, Lund S. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 2005; 54: 928-934
26. Roche E, Farfari S, Witters LA, Assimacopoulos-Jeannet F, Thumelin S, Brun T, Corkey BE, SahaAK, Prentki M. Long-term exposure of beta-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes 1998; 47:1086-1094 (Pubitemid 28294551)
27. Kahn BB, Alquier T, Carting D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1:15-25 (Pubitemid 43960587)
28. Ravnskjaer K, Boergesen M, Dalgaard LT, Mandrup S. Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation. J Mol Endocrinol 2006; 36: 289-299